ReviewImmuno-oncology technology2022
Clinical landscape of LAG-3-targeted therapy.
L Chocarro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewImmuno-oncology technology2022
L Chocarro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.